Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Brindisi – page 4

43 clinical trials in Brindisi, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Brindisi at a glance
43
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

43 trials in Brindisi

Open in trial search

Breast cancer

Not recruiting

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Hormone receptor positive breast cancer+1

Not recruiting

Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:ETOP IBCSG Partners Foundation

Breast cancer+2

Not recruiting

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:F. Hoffmann-La Roche AG

Parkinson's disease

Not recruiting

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:5,7-Dimethyl-N-((1R,4R)-4-(Pentyloxy)Cyclohexyl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
  • Sponsor:Bial R&D Investments S.A.

Thermal burn

Not recruiting

Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Queen's University

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Pfizer Inc.

Non-small cell lung cancer

Not recruiting

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Brindisi

What the registry says about research in the country

01 Hematologic Oncology

Innovative clinical trials focusing on Acute Myeloid Leukemia and Follicular Lymphoma, investigating new therapeutic approaches including targeted treatments and immunotherapy combinations.

  • Gemtuzumab Ozogamicin therapy evaluation
  • Shortened chemotherapy with immunotherapy
  • Mocravimod in transplant patients

Research aims to improve treatment outcomes and patient survival rates through personalized therapeutic strategies.

02 Breast Cancer Research

Comprehensive studies on various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease variants.

  • Hormone therapy optimization
  • Novel drug combinations
  • Treatment sequencing strategies

Investigations aim to enhance treatment efficacy through targeted therapies and precision medicine approaches.

03 Gynecologic Oncology

Advanced research in ovarian cancer and related conditions, with particular emphasis on maintenance therapies and biomarker-driven treatment approaches.

  • BRCA-related studies
  • Maintenance therapy evaluation
  • Novel combination treatments

Studies focus on improving progression-free survival and identifying effective treatment strategies.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.